Clinical Trials in Albury, New South Wales
19 recruiting
Showing 1–18 of 18 trials
Recruiting
Phase 2Phase 3
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Pfizer550 enrolled32 locationsNCT07226999
Recruiting
Phase 1
A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation
Advanced Solid Tumors Harboring KRAS G12C Mutation
Bayer104 enrolled10 locationsNCT06659341
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
CRC (Colorectal Cancer)
Incyte Corporation700 enrolled272 locationsNCT07284849
Recruiting
Phase 2
Working Out M0 Bipolar Androgen Therapy
Prostate Cancer
Australian and New Zealand Urogenital and Prostate Cancer Trials Group69 enrolled12 locationsNCT06594926
Recruiting
Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Prostate Cancer
Astellas Pharma Global Development, Inc.900 enrolled241 locationsNCT02960022
Recruiting
Phase 3
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Hoffmann-La Roche1,000 enrolled165 locationsNCT03683251
Recruiting
Phase 2
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
ADARx Pharmaceuticals, Inc.240 enrolled17 locationsNCT06990269
Recruiting
Phase 2
YN001-004 in Patients With Coronary Atherosclerosis in Australia
Coronary Artery DiseaseCoronary Atherosclerotic Disease
Beijing Inno Medicine Co., Ltd.24 enrolled7 locationsNCT06700720
Recruiting
Phase 2
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Myelodysplastic SyndromesCytopenia
Takeda160 enrolled47 locationsNCT04419649
Recruiting
Phase 3
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
Endometrial Cancer
Karyopharm Therapeutics Inc276 enrolled217 locationsNCT05611931
Recruiting
Not Applicable
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Age-Related Macular DegenerationIntermediate AMDAge-related Macular Degeneration (ARMD)
i-Lumen Scientific AUS PTY LTD100 enrolled9 locationsNCT06662162
Recruiting
Phase 1
Trial of INI-4001 in Patients With Advanced Solid Tumours
Advanced Solid Tumor
Inimmune Corporation50 enrolled3 locationsNCT06302426
Recruiting
Phase 1Phase 2
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Chronic Myelomonocytic LeukemiaMyelodysplastic Syndrome With Excess Blasts-2Leukemia, Myeloid, Acute+2 more
Aptose Biosciences Inc.240 enrolled34 locationsNCT03850574
Recruiting
Phase 1
DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Lymphoma, Non-Hodgkin
Dizal Pharmaceuticals230 enrolled5 locationsNCT05824585
Recruiting
Phase 2
A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study
Esophageal Cancer
Australasian Gastro-Intestinal Trials Group54 enrolled9 locationsNCT06290505
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Diabetic RetinopathyNPDR - Non Proliferative Diabetic Retinopathy
Vantage Biosciences Ltd100 enrolled26 locationsNCT06770933
Recruiting
Phase 2
Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC
Prostatic Neoplasms, Castration-Resistant
Leiden University Medical Center168 enrolled19 locationsNCT05393791
Recruiting
Phase 2
Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients
Solid Tumor, Adult
Omico96 enrolled13 locationsNCT06003621